Manifestations of the hyperadrenergic state after acute brain injury

Holly Hinson, Kevin N. Sheth

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Hyperadrenergic activity leading to autonomic dysfunction after acute brain injury is an underrecognized, yet important source of complications following a variety of neurologic injuries. Autonomic dysfunction may prolong ICU stay and increase healthcare costs driven by extensive diagnostic workups and/or ensuing complications. In this review article, we intend to illustrate commonalities between various hyperadrenergic states in acquired brain injury. Specifically, this review will focus on autonomic dysfunction in two common conditions in the neurocritical care unit, traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH). RECENT FINDINGS: Elevated levels of catecholamines have been well documented in SAH and to a lesser extent in paroxysmal sympathetic hyperactivity, hinting at the underlying increased sympathetic tone in both disease states. The resultant hyperadrenergic state may manifest with vital sign alterations, or end-organ dysfunction such as heart failure. Neuroimaging and limited clinical data have elucidated some information regarding underlying mechanisms, but the gaps in understanding have thus far limited prospective clinical trials. A multitude of therapeutic options to reduce adrenergic tone have been employed with varying degrees of success. SUMMARY: The pathophysiology of autonomic dysfunction is incompletely understood and treatment options are few. However, recognizing hyperadrenergic commonality in disparate neurologic disease may facilitate novel inquiries into lesion localization and therapeutics. It is possible that adrenergic blockade may diminish or abrogate end-organ dysfunction in TBI and SAH.

Original languageEnglish (US)
Pages (from-to)139-145
Number of pages7
JournalCurrent Opinion in Critical Care
Volume18
Issue number2
DOIs
StatePublished - Apr 2012

Fingerprint

Traumatic Brain Hemorrhage
Traumatic Subarachnoid Hemorrhage
Adrenergic Agents
Brain Injuries
Nervous System Trauma
Vital Signs
Subarachnoid Hemorrhage
Nervous System Diseases
Neuroimaging
Health Care Costs
Catecholamines
Heart Failure
Clinical Trials
Therapeutics
Traumatic Brain Injury

Keywords

  • dysautonomia
  • hyperadrenergic activity
  • paroxysmal sympathetic hyperactivity
  • subarchnoid hemorrhage
  • traumatic brain injury

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Manifestations of the hyperadrenergic state after acute brain injury. / Hinson, Holly; Sheth, Kevin N.

In: Current Opinion in Critical Care, Vol. 18, No. 2, 04.2012, p. 139-145.

Research output: Contribution to journalArticle

@article{cfb2551383b74096bedd4f470b58ca5f,
title = "Manifestations of the hyperadrenergic state after acute brain injury",
abstract = "PURPOSE OF REVIEW: Hyperadrenergic activity leading to autonomic dysfunction after acute brain injury is an underrecognized, yet important source of complications following a variety of neurologic injuries. Autonomic dysfunction may prolong ICU stay and increase healthcare costs driven by extensive diagnostic workups and/or ensuing complications. In this review article, we intend to illustrate commonalities between various hyperadrenergic states in acquired brain injury. Specifically, this review will focus on autonomic dysfunction in two common conditions in the neurocritical care unit, traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH). RECENT FINDINGS: Elevated levels of catecholamines have been well documented in SAH and to a lesser extent in paroxysmal sympathetic hyperactivity, hinting at the underlying increased sympathetic tone in both disease states. The resultant hyperadrenergic state may manifest with vital sign alterations, or end-organ dysfunction such as heart failure. Neuroimaging and limited clinical data have elucidated some information regarding underlying mechanisms, but the gaps in understanding have thus far limited prospective clinical trials. A multitude of therapeutic options to reduce adrenergic tone have been employed with varying degrees of success. SUMMARY: The pathophysiology of autonomic dysfunction is incompletely understood and treatment options are few. However, recognizing hyperadrenergic commonality in disparate neurologic disease may facilitate novel inquiries into lesion localization and therapeutics. It is possible that adrenergic blockade may diminish or abrogate end-organ dysfunction in TBI and SAH.",
keywords = "dysautonomia, hyperadrenergic activity, paroxysmal sympathetic hyperactivity, subarchnoid hemorrhage, traumatic brain injury",
author = "Holly Hinson and Sheth, {Kevin N.}",
year = "2012",
month = "4",
doi = "10.1097/MCC.0b013e3283513290",
language = "English (US)",
volume = "18",
pages = "139--145",
journal = "Current Opinion in Critical Care",
issn = "1070-5295",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Manifestations of the hyperadrenergic state after acute brain injury

AU - Hinson, Holly

AU - Sheth, Kevin N.

PY - 2012/4

Y1 - 2012/4

N2 - PURPOSE OF REVIEW: Hyperadrenergic activity leading to autonomic dysfunction after acute brain injury is an underrecognized, yet important source of complications following a variety of neurologic injuries. Autonomic dysfunction may prolong ICU stay and increase healthcare costs driven by extensive diagnostic workups and/or ensuing complications. In this review article, we intend to illustrate commonalities between various hyperadrenergic states in acquired brain injury. Specifically, this review will focus on autonomic dysfunction in two common conditions in the neurocritical care unit, traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH). RECENT FINDINGS: Elevated levels of catecholamines have been well documented in SAH and to a lesser extent in paroxysmal sympathetic hyperactivity, hinting at the underlying increased sympathetic tone in both disease states. The resultant hyperadrenergic state may manifest with vital sign alterations, or end-organ dysfunction such as heart failure. Neuroimaging and limited clinical data have elucidated some information regarding underlying mechanisms, but the gaps in understanding have thus far limited prospective clinical trials. A multitude of therapeutic options to reduce adrenergic tone have been employed with varying degrees of success. SUMMARY: The pathophysiology of autonomic dysfunction is incompletely understood and treatment options are few. However, recognizing hyperadrenergic commonality in disparate neurologic disease may facilitate novel inquiries into lesion localization and therapeutics. It is possible that adrenergic blockade may diminish or abrogate end-organ dysfunction in TBI and SAH.

AB - PURPOSE OF REVIEW: Hyperadrenergic activity leading to autonomic dysfunction after acute brain injury is an underrecognized, yet important source of complications following a variety of neurologic injuries. Autonomic dysfunction may prolong ICU stay and increase healthcare costs driven by extensive diagnostic workups and/or ensuing complications. In this review article, we intend to illustrate commonalities between various hyperadrenergic states in acquired brain injury. Specifically, this review will focus on autonomic dysfunction in two common conditions in the neurocritical care unit, traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH). RECENT FINDINGS: Elevated levels of catecholamines have been well documented in SAH and to a lesser extent in paroxysmal sympathetic hyperactivity, hinting at the underlying increased sympathetic tone in both disease states. The resultant hyperadrenergic state may manifest with vital sign alterations, or end-organ dysfunction such as heart failure. Neuroimaging and limited clinical data have elucidated some information regarding underlying mechanisms, but the gaps in understanding have thus far limited prospective clinical trials. A multitude of therapeutic options to reduce adrenergic tone have been employed with varying degrees of success. SUMMARY: The pathophysiology of autonomic dysfunction is incompletely understood and treatment options are few. However, recognizing hyperadrenergic commonality in disparate neurologic disease may facilitate novel inquiries into lesion localization and therapeutics. It is possible that adrenergic blockade may diminish or abrogate end-organ dysfunction in TBI and SAH.

KW - dysautonomia

KW - hyperadrenergic activity

KW - paroxysmal sympathetic hyperactivity

KW - subarchnoid hemorrhage

KW - traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=84858795711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858795711&partnerID=8YFLogxK

U2 - 10.1097/MCC.0b013e3283513290

DO - 10.1097/MCC.0b013e3283513290

M3 - Article

C2 - 22322258

AN - SCOPUS:84858795711

VL - 18

SP - 139

EP - 145

JO - Current Opinion in Critical Care

JF - Current Opinion in Critical Care

SN - 1070-5295

IS - 2

ER -